Comparing Different Timings for Periodontal Re-evaluation After Non-surgical Periodontal Therapy (NSPT)

Launched by UNIVERSITY OF PARMA · Oct 8, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how the timing of follow-up visits after non-surgical treatment for gum disease (periodontitis) affects healing. Specifically, researchers want to see how many patients have healthy gum pockets (those that are less than 5 mm deep and don’t bleed) when they are checked at different times: 3-4 months, 6-8 months, and 12 months after their initial treatment. The goal is to find the best time to evaluate healing to help improve future treatments.

To participate in this study, you must be at least 18 years old and generally healthy, with signs of gum disease. You should not have had any deep cleaning treatments in the past year or be on certain medications that could affect your gums. If you join, you will have follow-up appointments at different intervals to see how well your gums are healing. This study is currently looking for participants at the University of Parma, and your involvement could help improve treatments for gum disease in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Systemically healthy males and females ≥18 years old
• • Willingness to read and sign a copy of the Informed Consent Form after reading the Patient Information Sheet, and after the nature of the study has been fully explained
• • Clinical evidence of periodontitis, defined as the presence of interdental clinical attachment loss detectable at ≥2 non-adjacent teeth or buccal or oral clinical attachment loss ≥3mm with pocketing \>3 mm detectable at ≥2 teeth (Tonetti et al., 2018)
• • Not having received subgingival instrumentation within the previous 12 months
• Exclusion Criteria:
• • Medical history that includes serious medical conditions or transmittable diseases (e.g. serious cardiovascular disease, organ transplant, renal failure, AIDS, viral etc.).
• • Antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
• • In treatment with drugs that induce gingival overgrowth
• • History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
• • History of alcohol or drug abuse.
• • Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results).
• • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.